Work

NE15 Enhanced oxidative damage in multihormonal hypopituitarism: a prospective study assessing the impact of hormone replacement therapy

Year: 2026
Type: conference-abstract
Abstract: Background While primary hypothyroidism and growth hormone deficiency are associated with elevated oxidative damage, and adequate hormone replacement therapies reduce this adverse effect, data on the impact of hypopituitarism on oxidative stress remain limited. Purpose The aim of the present study was to evaluate the impact of optimised hormone replacement on oxidative damage in patients with hypopituitarism. Methods In patients with multihormonal hypopituitarism of various degree (involving GH, FSH/LH, TSH, and ACTH deficiencies) (n=20), the concentrations of lipid peroxidation products (LPO), i.e. malondialdehyde and 4-hydroxyalkenals (MDA+4-HDA), were compared before and after 3-18 months of treatment. The control group (n=19) included patients with normal pituitary function. Results In patients with hypopituitarism, LPO levels were significantly higher than in control (3.84±0.74 vs 3.03±0.69ng/mL; p< 0.01). Total cholesterol, LDL-C and triglyceride concentrations were also significantly higher in the study group compared to control (p<0.01, p=0.02, and p=0.05, respectively). During hormone replacement therapy, a significant reduction in LPO levels was observed (3.84±0.74 vs 3.15±1.01ng/mL, p=0.01), with no significant difference compared to the control (3.15±1.01 vs 3.03±0.69ng/mL, p=0.69). In linear regression analysis, a significant negative association was observed between the increment in fT4 (ΔfT4) and the decrement in LPO (ΔMDA+4HDA) (B=-1.92, p=0.01). Conclusions Multihormonal hypopituitarism is associated with enhanced oxidative damage to macromolecules. Optimisation of hormone replacement therapies, best documented by L-thyroxine treatment, restores redox balance.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,292
OpenAlex ID: W7204458306
Cites:
Cited by:
Related to: 10